(0.15%) 5 214.25 points
(0.14%) 39 050 points
(0.00%) 18 196 points
(-0.37%) $78.19
(-0.50%) $2.18
(-0.09%) $2 329.00
(0.21%) $27.67
(1.92%) $983.45
(-0.05%) $0.928
(0.30%) $10.86
(0.05%) $0.796
(-0.06%) $91.29
Live Chart Being Loaded With Signals
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology...
Stats | |
---|---|
本日の出来高 | 182 486 |
平均出来高 | 10 347.00 |
時価総額 | 0.00 |
EPS | $0.449 ( 2021-12-30 ) |
Last Dividend | $1.438 ( 2022-01-13 ) |
Next Dividend | $0 ( N/A ) |
P/E | 248.89 |
ATR14 | $4.11 (2.32%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-03-07 | Shirley Brady | Sell | 3 624 | Common stock, par value $.001 |
2022-03-07 | Shirley Brady | Sell | 3 624 | Common stock, par value $.001 |
2022-03-07 | Trerotola Matthew L. | Sell | 12 002 | Common stock, par value $.001 |
2022-03-07 | Trerotola Matthew L. | Sell | 12 002 | Common stock, par value $.001 |
2022-03-07 | Tandy Bradley J | Sell | 1 498 | Common stock, par value $.001 |
INSIDER POWER |
---|
0.00 |
Last 94 transactions |
Buy: 2 494 141 | Sell: 999 967 |
ボリューム 相関
Colfax Corporation 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Colfax Corporation 相関 - 通貨/商品
Colfax Corporation 財務諸表
Annual | 2021 |
収益: | $3.85B |
総利益: | $1.61B (41.87 %) |
EPS: | $2.78 |
FY | 2021 |
収益: | $3.85B |
総利益: | $1.61B (41.87 %) |
EPS: | $2.78 |
FY | 2020 |
収益: | $3.07B |
総利益: | $1.29B (41.95 %) |
EPS: | $0.450 |
FY | 2019 |
収益: | $3.33B |
総利益: | $1.40B (42.11 %) |
EPS: | $-20.50 |
Financial Reports:
No articles found.
Colfax Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $1.501 | 2019-04-11 |
Last Dividend | $1.438 | 2022-01-13 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 12 | -- |
Total Paid Out | $17.32 | -- |
Avg. Dividend % Per Year | 0.89% | -- |
Score | 3.35 | -- |
Div. Sustainability Score | 7.80 | |
Div.Growth Potential Score | 1.388 | |
Div. Directional Score | 4.59 | -- |
Year | Amount | Yield |
---|---|---|
2019 | $4.38 | 4.28% |
2020 | $5.75 | 3.60% |
2021 | $5.75 | 3.69% |
2022 | $1.438 | 0.78% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
SJT | Dividend Royal | 2023-11-29 | Monthly | 39 | 12.52% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
ORC | Dividend Royal | 2023-11-29 | Monthly | 12 | 9.23% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0256 | 1.500 | 9.49 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0116 | 1.200 | 9.61 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0242 | 1.500 | -0.842 | -1.264 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.25 | 0.800 | 3.75 | 3.00 | [1 - 3] |
quickRatioTTM | 1.327 | 0.800 | 6.90 | 5.52 | [0.8 - 2.5] |
cashRatioTTM | 0.703 | 1.500 | 7.21 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.267 | -1.500 | 5.55 | -8.32 | [0 - 0.6] |
interestCoverageTTM | 2.91 | 1.000 | -0.0349 | -0.0349 | [3 - 30] |
operatingCashFlowPerShareTTM | 13.84 | 2.00 | 5.39 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 9.79 | 2.00 | 5.11 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.493 | -1.500 | 8.03 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.419 | 1.000 | 6.36 | 6.36 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0547 | 1.000 | -0.905 | -0.905 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.157 | 1.000 | -0.241 | -0.241 | [0.2 - 2] |
assetTurnoverTTM | 0.453 | 0.800 | -0.316 | -0.253 | [0.5 - 2] |
Total Score | 7.80 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 46.35 | 1.000 | 5.42 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0242 | 2.50 | -0.542 | -1.264 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 9.79 | 2.00 | 6.74 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 13.84 | 2.00 | 5.39 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.649 | 1.500 | -7.66 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0924 | 1.000 | -0.190 | 0 | [0.1 - 0.5] |
Total Score | 1.388 |
Colfax Corporation
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine/life sciences, pipelines, mobile/off-highway equipment, oil, gas, and mining markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and direct and independent distributors under the DJO brand. Colfax Corporation was founded in 1860 and is based in Wilmington, Delaware.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。